Prevalence of renal and bone risk factors among individuals prescribed oral pre-exposure prophylaxis for HIV

OBJECTIVES: The only available oral pre-exposure prophylaxis (PrEP) regimens approved in the United States to prevent HIV infection during the period covered by this study were emtricitabine/tenofovir alafenamide (F/TAF) and emtricitabine/tenofovir disoproxil fumarate (F/TDF). Both agents have simil...

Descripción completa

Detalles Bibliográficos
Autores principales: Fields, Sheldon D., Gruber, Joshua, Clue, Jamaal, Rey, Gabriel Gomez, Cuervo, Helena Díaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Original Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922808/
https://www.ncbi.nlm.nih.gov/pubmed/36793391
http://dx.doi.org/10.1016/j.ijregi.2023.01.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922808/
https://www.ncbi.nlm.nih.gov/pubmed/36793391
http://dx.doi.org/10.1016/j.ijregi.2023.01.004

Ejemplares similares